The reduction of ADMA on hnRNP-A1 was demonstrated in both cancer lines and human PBMCs and this prompted us to develop an LC–MS/MS method aimed at detecting and quantifying dimethylarginine 225 levels on hnRNP-A1 in human PBMCs. This evidence concerns the gene HNRNPA1 and cancer.